Nexalin Technology, Inc. (NXL) stock
NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.44−0.06 (-4.00%)
Close on Nov 18, 2026Market cap $31.73MP/E –Yield –
Nexalin Technology price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Nexalin Technology's price to sales ratio was 161.1× on Nov 11, 2026, against 182.8× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 161.1× | +54.6 |
| 2024 | Feb 29, 2024 | 106.5× | −29.7 |
| 2023 | Dec 29, 2023 | 136.2× | +11.0 |
| 2022 | Dec 30, 2022 | 125.2× | – |
See a number that looks wrong?